Chlamydia and infertility
Chlamydia, caused by the bacterium Chlamydia trachomatis, is the most often diagnosed sexually transmitted illness, affecting roughly 5% to 10% of sexually active young people. Chlamydia has the potential to permanently damage a woman’s reproductive system making it complicated or impractical to get pregnant later.The majority of persons with chlamydia have no symptoms. If left untreated, chlamydia can spread to the womb, ovaries, and fallopian tubes in women. It can progress to pelvic inflammatory disease (PID). PID can lead to various significant issues such as ectopic pregnancy and frequently culminates in adhesions and blockage of the Fallopian tubes, resulting in infertility and trouble getting pregnant. Chlamydia can create complications during pregnancy and labour if left untreated. Chlamydia can induce early membrane rupture and preterm labour in pregnant women. Chlamydia can be transmitted from the mother to the infant during labour, infecting the newborn’s eyes or lungs.
Endometrioma Test
Pregnancy begins with the embryo’s implantation in the uterus’s endometrial lining, forsooth. The endometrial lining has a range of abundant beneficial microbial flora present in equilibrium. A disturbance in the equilibrium of the endometrial flora, either the presence of too few or too many beneficial bacteria, can impact implantation. Embryo implantation failure has been linked to an imbalance in the endometrial flora. The endometrioma test is a diagnostic technique for determining the flora of the endometrium. We can treat this imbalance by advising the optimal probiotic or antibiotic medication to balance the endometrial flora and boost the chances of your pregnancy. Recurrent implantation failures, such as recurrent miscarriages or multiple failed IVF procedures, including the transfer of embryos deemed normal by genetic testing, may benefit from an endometrioma test. It’s a straightforward test involving a tiny endometrial sample with a pipelle. The sample is collected in a collection kit and delivered to a lab for testing. The sample is analysed using the most up-to-date next-generation sequencing technologies, and the findings are ready in three weeks